OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU (“PHARMENTERPRISES”)
发明人:
Vladimir Evgenievich Nebolsin,Andrei Yurievich Egorov
申请号：
US14915475
公开号：
US09730915B2
申请日:
2014.09.01
申请国别(地区):
US
年份:
2017
代理人:
摘要：
The invention relates to medicine, in particular, to a method for preventing and/or treating a disease associated with a reduced density of interferon receptors, the method comprising administering an effective amount of glutaryl histamine or a pharmaceutically acceptable salt thereof. Said disease may be hepatitis B, herpes, papilloma virus infection, or multiple sclerosis. The invention also relates to a pharmaceutical composition for prevention and/or treatment of diseases associated with a reduced density of interferon receptors, wherein the composition comprises an effective amount of glutaryl histamine or a pharmaceutically acceptable salt thereof. The invention solves a problem of providing a novel agent effective for overcoming a resistance to interferon therapy in diseases selected from the group including hepatitis B, herpes, papilloma virus infection, or multiple sclerosis.
